
SI-BONE Inc (SIBN) Stock Forecast & Price Target
SI-BONE Inc (SIBN) Analyst Ratings
Bulls say
SI-BONE Inc. has demonstrated strong financial performance with a year-over-year revenue growth of approximately 23%, totaling $46.4 million in the second quarter of 2025. The company's gross margin also improved, increasing about 80 basis points year-over-year to reach 79.8%, indicating enhanced operational efficiency. Furthermore, the positive momentum in sales productivity has led to an upward revision of the 2025 revenue estimate to $196.5 million, reflecting confidence in continued growth and market expansion.
Bears say
SI-BONE Inc faces significant challenges, as the global spine market has been hindered by pricing and procedure headwinds, resulting in slowed growth in the low-single digits. This environment creates a risk for SI-BONE, as potential declines in market share due to payer preferences for competitive products could adversely impact the company's revenue. Additionally, SI-BONE's low EV/sales/growth ratio of 0.19x, compared to its peer group's median of 0.34x, underscores concerns about its growth potential and overall financial performance.
This aggregate rating is based on analysts' research of SI-BONE Inc and is not a guaranteed prediction by Public.com or investment advice.
SI-BONE Inc (SIBN) Analyst Forecast & Price Prediction
Start investing in SI-BONE Inc (SIBN)
Order type
Buy in
Order amount
Est. shares
0 shares